白人美国人醛固酮腺瘤的靶向分子特征
该研究采用CYP11B2免疫组化引导的新一代测序,分析75例白人美国人醛固酮腺瘤(APA)的体细胞突变。结果显示88%的APA存在体细胞突变,最常见为KCNJ5(43%),其次为CACNA1D(21%)、ATP1A1(17%)、ATP2B3(4%)和CTNNB1(3%),并发现5个既往未报道的突变。
要点
- CYP11B2免疫组化引导测序在88%的APA中检出体细胞突变。
- KCNJ5突变最常见(43%),且在女性中更频繁(70% vs 24%)。
- 发现5个既往未报道的突变,扩展了APA突变谱。
核心结论
- CYP11B2表达肾上腺肿瘤的综合NGS在88%的APA中检出醛固酮驱动基因的体细胞突变,高于既往传统方法的研究。
研究设计与样本
- 研究纳入在密歇根大学接受肾上腺切除术的白人美国人原发性醛固酮增多症患者,从75例经CYP11B2免疫组化鉴定的APA中提取基因组DNA,对APA中突变基因的全编码区进行NGS以识别体细胞突变。
主要发现
- 75例APA中66例(88%)检出体细胞突变。
- 在有体细胞突变的APA中,6例小于共存的CYP11B2阴性肾上腺皮质腺瘤。
- 最常见的突变基因是KCNJ5(43%),其次为CACNA1D(21%)、ATP1A1(17%)、ATP2B3(4%)和CTNNB1(3%)。
- 除既往报道的突变外,还发现5个既往未报道的突变(KCNJ5两个,ATP1A1、ATP2B3和CACNA1D各一个)。
- KCNJ5突变在女性中更频繁(70% vs 男性24%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Somatic mutations have been identified in more than half of aldosterone-producing adenomas (APAs) through mutation hotspot sequencing. The underlying pathogenesis of inappropriate aldosterone synthesis in the remaining population is still unknown. OBJECTIVE: To investigate the prevalence and spectrum of somatic mutations in APAs using an aldosterone synthase (CYP11B2) immunohistochemistry (IHC)‒guided next-generation sequencing (NGS) approach. METHODS: Formalin-fixed paraffin-embedded adrenal tissue from white American patients with primary aldosteronism who underwent adrenalectomy at the University of Michigan was used. Genomic DNA was isolated from 75 APAs (identified by CYP11B2 IHC). NGS was performed to identify somatic mutations by sequencing the entire coding region of a panel of genes mutated in APAs. RESULTS: Somatic mutations were identified in 66 of 75 APAs (88%). Of the APAs with somatic mutations, six were smaller than coexisting CYP11B2-negative adrenocortical adenomas. The most frequently mutated gene was KCNJ5 (43%), followed by CACNA1D (21%), ATP1A1 (17%), ATP2B3 (4%), and CTNNB1 (3%). In addition to identification of previously reported mutations, we identified five previously unreported mutations (two in KCNJ5, one in ATP1A1, one in ATP2B3, and one in CACNA1D genes). KCNJ5 mutations were more frequent in women (70% vs 24% in men). CONCLUSION: Comprehensive NGS of CYP11B2-expressing adrenal tumors identified somatic mutations in aldosterone-driving genes in 88% of APAs, a higher rate than in previous studies using conventional approaches.
引用
- Nanba K, Omata K, Else T, et al. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans. J Clin Endocrinol Metab. 2018. PMID: 30085035. doi:10.1210/jc.2018-01004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。